I'm still in the whole on this one. Bought at 5 road it up to 13 and back down. I think I'll hold.

The market today... are you still around? I miss your comments...

For speculative stock, I like this health sector company. Priced low.

Looks like a strong run up antisipating the anouncement of the DOD contract. Anyone have any other catalists/ideas?

radiation poisoning cure

Well, the market today (do you have a more conventional name?), do you have any negatives on this stock? Other than the time required to do testing and the wait for contracts to be awarded I mean. The DOD decision is due in the late summer, which is genuine governmental gibberish for the fall.

I'm very impressed with your due dilligence.

Tom

Thomas, The way i see it....................

The company has many more potential compounds in the pipeline because of its ability to target drugs from the secretions of the symbiotic parasites that have evolved with our cellular structures over the last 1 million years.

The company has unique intellectual property protection on numerous of these bugs. That will lead to drugs for strokes, renal failure.

Buffalo Facility Appears State of the Art

Saw this comment on another message board………The blogger commented on Gudkov's Buffalo lab and facilities as being state of the art.

He noted, “I have a friend who lives in Buffalo who recently visited Andrei Gudkov's lab and CBLI's future home facility. Gudkov is now the head of cellular stress at Roswell Park Cancer Center as well as being the Chief Scientific Officer for CBLI.

Roswell has a new state of the art facility that any cancer researcher would kill for. CBLI has a similar licensing arrangement with Roswell that they have with the Cleveland Clinic.

CBLI gets exclusive rights to anything Gudkov is working on or collaborates on. His lab will have nearly 40 researchers working and cbli gets full benefit.

In addition Gudkov is now the head of research at Roswell and it has a $125 million budget. This allows him some sway with other world class researchers in his field even though the other labs are not tied direclty to the cbli deal.

Buffalo Facility Appears State of the Art

Saw this comment on another message board………The blogger commented on Gudkov's Buffalo lab and facilities as being state of the art.

He noted, “I have a friend who lives in Buffalo who recently visited Andrei Gudkov's lab and CBLI's future home facility. Gudkov is now the head of cellular stress at Roswell Park Cancer Center as well as being the Chief Scientific Officer for CBLI.

Roswell has a new state of the art facility that any cancer researcher would kill for. CBLI has a similar licensing arrangement with Roswell that they have with the Cleveland Clinic.

CBLI gets exclusive rights to anything Gudkov is working on or collaborates on. His lab will have nearly 40 researchers working and cbli gets full benefit.

In addition Gudkov is now the head of research at Roswell and it has a $125 million budget. This allows him some sway with other world class researchers in his field even though the other labs are not tied direclty to the cbli deal.

This is all in addition to the 30 plus researchers on cbli's employee list. There are very few companies with access to state of the art facilities such as this and also have a market cap below $200 million.

My friend who knows an enormous amount about such due diligence was very impressed. This should provide cbli numerous opportunities to test out their cancer drugs.

Unless there is some major negative developments, it's hard to see much negative with this security. The day traraders continue to make money on good news which is frustrating but htere is a lot of favorable information to come from this company I feel. There are at least 3 drugs in the pipeline with very promising test results so far.....